Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/03/21
Rigel Announces Conference Call and Webcast to Report Third Quarter 2021 Financial Results and Business UpdatePRNewsWire • 10/26/21
Rigel Pharma: Positive Data Supports Use Of Tavalisse In COVID-19 As Variants Subterfuge VaccinesSeeking Alpha • 09/06/21
Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious DiseasesPRNewsWire • 09/01/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rigel Pharmaceuticals, Inc. - RIGLNewsfile Corp • 08/17/21
Implied Volatility Surging for Rigel Pharmaceuticals (RIGL) Stock OptionsZacks Investment Research • 08/11/21
Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
Rigel Reports Second Quarter 2021 Financial Results and Provides Business UpdatePRNewsWire • 08/03/21
Earnings Preview: Rigel Pharmaceuticals (RIGL) Q2 Earnings Expected to DeclineZacks Investment Research • 07/27/21
Rigel Announces Conference Call and Webcast to Report Second Quarter 2021 Financial Results and Business UpdatePRNewsWire • 07/27/21
New TAVALISSE® Data Analyses To Be Presented at International Society on Thrombosis and Haemostasis (ISTH) 2021 CongressPRNewsWire • 07/14/21
Rigel Pharmaceuticals: A Patented FDA Approved Drug That May Successfully Fight COVID-19Seeking Alpha • 06/14/21